Privia Health (PRVA) 8-K: Material Event Highlights Key Risks

Privia Health Group, Inc. (PRVA) filed a Current Report describing material risks and uncertainties affecting its business.

Rhea-AI Filing Summary

Privia Health Group, Inc. (PRVA) filed a Current Report describing material risks and uncertainties affecting its business. The filing highlights regulatory and compliance exposure in a heavily regulated healthcare environment, the complexity of relationships with medical groups and Privia providers, and execution risks for its growth strategy and proprietary cloud-based technology rollout. It notes reliance on key vendors such as athenahealth, Inc., potential reimbursement rate pressure from government and private payers, cybersecurity and privacy risks related to protected health information, and workforce availability and cost pressures. The report references risk disclosures through year ended December 31, 2024 and states information is current as of the report date.

Positive

• Transparent disclosure of a broad set of operational and regulatory risks, including vendor and cybersecurity exposure
• Explicit reference to prior risk disclosures through December 31, 2024, linking this report to existing SEC filings

Negative

• Regulatory and compliance risk across federal and state healthcare laws including HIPAA
• Execution risk for implementing the proprietary cloud-based technology for physicians and medical groups
• Vendor concentration reliance on athenahealth could cause operational disruptions
• Reimbursement pressure from governmental and third-party payers may reduce revenue
• Cybersecurity and privacy breach risks involving protected health information
• Workforce availability and cost pressures could increase operating expenses

Insights

Healthcare Compliance Analyst

Filing emphasizes compliance and regulatory exposure across state and federal healthcare rules.

The company lists extensive healthcare law and privacy obligations, including risks tied to the Health Insurance Portability and Accountability Act of 1996, which create ongoing operational and reporting requirements. Noncompliance could affect contracts and reimbursements.

Key dependencies include maintaining strong compliance programs and monitoring changing legal interpretations; investors should note this as a standing operational risk without specific incidents disclosed.

Operations & Vendor Risk Specialist

The filing flags concentration risk from core vendors and execution risk for technology and growth initiatives.

Privia calls out reliance on its primary electronic medical record vendor, athenahealth, Inc., and the challenge of timely implementing its end-to-end cloud solution for physicians and new medical groups. Service disruptions or integration delays could impair operations.

Monitor third-party service continuity and the pace of technology rollouts; no specific timelines or remediation steps are provided in this report.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What risks does Privia Health (PRVA) identify in the 8-K?

The filing lists regulatory and compliance risks, complexities with medical group relationships, technology implementation and growth execution risks, reliance on vendors like athenahealth, Inc., reimbursement pressure, cybersecurity and privacy risks, and workforce availability and cost pressures.

Does the 8-K mention specific vendor reliance for PRVA?

Yes, the filing specifically names reliance on the primary electronic medical record vendor, athenahealth, Inc., as a material operational dependency.

Are there any financial results or earnings disclosed in this PRVA 8-K?

No. The document lists risk factors and exhibits but does not disclose earnings figures or other financial results.

What timeframe do the referenced risk disclosures cover for PRVA?

The filing references risk factors described in the Annual Report for the year ended December 31, 2024 and subsequent Quarterly Reports.

Does PRVA report any actual cybersecurity incidents in this 8-K?

No specific cybersecurity incidents are disclosed; the report describes cybersecurity and privacy as potential risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/23/2025 - 04:12 PM Learn about SEC filing dates

0001759655FALSE00017596552025-09-232025-09-23

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

_______________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 23, 2025

_________________________

Privia Health Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

_________________________

Delaware						001-40365			81-3599420
(State or other jurisdiction of incorporation or organization)						(Commission File No.)			(I.R.S. Employer Identification No.)
950 N. Glebe Rd.,
Suite 700
Arlington,			Virginia						22203
(Address of Principal Executive Offices)									(Zip Code)

(571) 366-8850

Registrant's telephone number, including area code

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.01 par value per share			PRVA			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events

On September 23, 2025, Privia Health Group, Inc. (the “Company”) issued a press release announcing the entry into a definitive agreement to acquire an Accountable Care Organization business from Evolent Health, Inc. for $100 million in cash at closing and up to an additional $13 million subject to final performance under the Medicare Shared Savings Program for 2025. Subject to applicable regulatory approvals and other customary closing conditions, the transaction is expected to close in the fourth quarter of 2025.

Forward-Looking Statements

This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things: our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2025. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.

Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this Current Report on Form 8-K is as of the date of this Current Report on Form 8-K, and the Company undertakes no duty to update this information unless required by law.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.						Description
99.1						Privia Health Group, Inc. Press Release Dated September 23, 2025
104						Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						PRIVIA HEALTH GROUP, INC.
Date: September 23, 2025						By:			/s/ David Mountcastle
									Name: David Mountcastle
									Title: Executive Vice President, Chief Financial Officer and Authorized Officer